Use of revised International Prognostic Scoring System (IPSS-R) in hypocellular myelodysplastic syndromes (MDS): Mayo Clinic experience.
Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7063-7063
10.1200/jco.2016.34.15_suppl.7063